Peter Greenleaf

2015 - Sucampo Pharmaceuticals

In 2015, Peter Greenleaf earned a total compensation of $3.2M as Chief Executive Officer and Chairman of the Board of Directors at Sucampo Pharmaceuticals, a 44% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$592,379
Option Awards$1,985,865
Salary$565,288
Other$8,843
Total$3,152,375

Greenleaf received $2M in option awards, accounting for 63% of the total pay in 2015.

Greenleaf also received $592.4K in non-equity incentive plan, $565.3K in salary and $8.8K in other compensation.

Rankings

In 2015, Peter Greenleaf's compensation ranked 2,992nd out of 13,638 executives tracked by ExecPay. In other words, Greenleaf earned more than 78.1% of executives.

ClassificationRankingPercentile
All
2,992
out of 13,638
78th
Division
Manufacturing
1,057
out of 5,190
80th
Major group
Chemicals And Allied Products
388
out of 1,854
79th
Industry group
Drugs
303
out of 1,528
80th
Industry
Pharmaceutical Preparations
240
out of 1,182
80th
Source: SEC filing on April 21, 2017.

Greenleaf's colleagues

We found six more compensation records of executives who worked with Peter Greenleaf at Sucampo Pharmaceuticals in 2015.

2015

Andrew Smith

Sucampo Pharmaceuticals

Chief Financial Officer

2015

Peter Kiener

Sucampo Pharmaceuticals

Chief Scientific Officer

2015

Thomas Knapp

Sucampo Pharmaceuticals

Chief Legal Officer

2015

Matthias Alder

Sucampo Pharmaceuticals

General Counsel

2015

Peter Lichtlen

Sucampo Pharmaceuticals

Chief Medical Officer

2015

Max Donley

Sucampo Pharmaceuticals

EVP, Global Human Resources, Information Technology and Strategy

News

In-depth

You may also like